Global Diabetes Care Devices Market, By Type (Blood Glucose Monitoring Systems, Insulin Delivery Devices, Diabetes Management Mobile Applications), By End-User (Hospitals, Diabetes Specialty Clinics, Self/Home Healthcare), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027
- Published Date: July 2021
- Report ID: BWC21411
- Available Format: PDF
- Page: 141
Report Overview
Diabetes is a chronic disease that occurs either when the pancreas fails to produce adequate insulin or when the body fails to use the insulin that it generates. Insulin is a hormone that helps to keep blood sugar levels in check.
Global Diabetes Care Devices Market- Industry Trends & Forecast Report 2027
The global diabetes care devices market was worth USD 8.9 billion in 2020 and is further projected to reach USD 14.0 billion by the year 2027, growing at the CAGR of 6.7% in the forecast period (2021-2027). Globally, the diabetes care devices market is progressing due to the increasing prevalence of diabetes around the world and the increasing acceptance of diabetes monitoring and management devices. As a result of raising awareness of this chronic disease, this market is expected to blossom during the forecast period.
Source: BlueWeave Consulting
Global Diabetes Care Devices Market- Overview
Diabetes is a chronic disease that occurs either when the pancreas fails to produce adequate insulin or when the body fails to use the insulin that it generates. Insulin is a hormone that helps to keep blood sugar levels in check. Over time, glucose (blood sugar) accumulates in the bloodstream without insulin, making it easier for it to become concentrated. The rise in blood sugar levels in your blood is caused by the accumulation of glucose in your bloodstream.
According to the World Health Organization, diabetes claimed the lives of 1.5 million people in 2019. There is currently no cure for diabetes; however, it can be controlled by managing one’s blood sugar levels. Diabetes increases a person's risk of developing heart disease, stroke, kidney disease, and eye problems, therefore diabetes care devices are used to reduce such risks. Diabetes care devices are used for monitoring and regulating the glucose level in a diabetic patient’s body. Blood glucose test strips, ketone monitors, insulin pens, syringes, pumps, and injectors are some of the most commonly used diabetes care devices.
Global Diabetes Care Devices Market Forecast and Trends
Growth Drivers
Rising Prevalence of Diabetes all around the world
The prevalence of diabetes in developing countries like China and India is increasing rapidly at an alarming rate. Diabetes was formerly a condition only associated with the geriatric population; however, it is becoming increasingly prevalent among young people as well. A report released by the American Diabetes Association revealed that the prevalence of diabetes among Americans under 20 is estimated to be about 210,000. The report further states that the incidence of type 1 and type 2 diabetes among youth was estimated to be 18,200 and 5,800, respectively, in 2014-15.
Increased urbanization, obesity, sedentary lifestyles, and lack of adequate knowledge about diabetes are some of the causes of the rising prevalence of diabetes. Thus, the market for diabetes care devices market is progressing swiftly and is estimated to gain traction in the forecast period.
Increasing Adoption of Technologically-advanced Diabetes Care Products
The need for diabetes care equipment is increasing as improved diabetes monitoring systems and treatment devices become more widely used. The healthcare facilities are rapidly installing and using diabetes care devices as they facilitate accurate measurements and monitoring. Simultaneously, the market players are also launching a wide range of diabetes care devices that cater to the needs of patients suffering from various types of diabetes. For instance, smart glucose level monitoring and insulin delivery solutions have been witnessing an increased demand as a result of their sophisticated technological features, which include integration with digital health solutions, data collection, as well as more precise and cost-effective management of diabetes. Thus, the wide acceptance of technologically advanced diabetes care devices is likely to drive the global diabetes care devices market in the forecast period.
Restraints
Nonavailability of Sufficient Reimbursement Insurance Policies
High diagnosis and treatment costs act as a significant deterrent to market growth. Developed nations like the USA, UK, Spain, Canada, and so on, have well-structured reimbursement insurance policies in place which boost the overall healthcare sector of such regions. However, in growing economies such as China, India, and South Korea, this concept of healthcare insurance is still relatively new. Potential markets, such as India, have some health insurance and reimbursement policies in place, but it will take some time for them to acquire traction. The adoption of advanced diabetes care devices is restricted as a result of this limitation. Moreover, lack of awareness regarding the benefits of such devices is also hindering the market growth.
Impact of Covid-19 on Global Diabetes Care Devices Market
With the sudden emergence of Covid-19-induced pandemic, the global diabetes care market experienced a mixed response. During the lockdown, the number of people visiting hospitals decreased dramatically, resulting in a decrease in demand for diabetes care devices. On the other hand, the trend of home-care monitoring and management of diabetes rose during the lockdown phase, which further propelled the demand for these devices. Furthermore, the Covid-19 pandemic may make a diabetic more vulnerable to severe illness. Thus, the rising number of Covid-19 cases may lead to a spike in the demand for diabetes care products in the foreseeable future.
Global Diabetes Care Devices Market - By Type
Based on types, the global diabetes care market is segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Blood glucose monitoring systems recorded the largest market share in the year 2020. The availability of technologically advanced devices and a range of diabetes care products such as smart insulin patches, insulin inhalers, closed-loop systems, etc. is significantly boosting the demand for blood glucose monitoring systems. However, diabetes management mobile applications are estimated to gain traction in the forecast period with a healthy CAGR.
Global Diabetes Care Devices Market - By End-User
Based on end-users, the global diabetes care market is categorized into hospitals, diabetes specialty clinics, and self-home healthcare. The hospital segment held the largest market share in 2020 owing to factors such as increasing hospitalization of patients, especially those belonging to the geriatric population. For monitoring and managing the blood sugar level, the accurate measurement of blood glucose is very crucial to avoid any complications. The demand for diabetes care devices in hospitals is estimated to boost in the forecast period due to the increasing adoption of advanced technology in these healthcare facilities.
Global Diabetes Care Devices Market - Regional Insights
Geographically, the global diabetes care devices market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among these regions, North America accounted for the largest share in the market. The rising number of people suffering from diabetes, along with the presence of major players in the region, are contributing to the growth of diabetes care devices in this region. However, the Asia-Pacific region is also estimated to witness a healthy CAGR in the forecast period owing to the increasing number of diabetes patients in the regions. According to a report released in 2016 by the WHO, China has 110 million people living with diabetes, which is nearly 10% of all adults. The report further states that the number is expected to rise to 150 million by the year 2040, with serious health, social, and economic consequences.
Competitive Landscape
The leading market players in the global diabetes care devices market are Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Rossmax International Ltd., Medtronic PLC, Sinocare, Inc., Ascensia Diabetes Care Holdings AG, Abbott, Rossmax International Ltd., Arkray, Inc., Dexcom, Inc., Bionime Corporation, Lifescan, Dr. Morepen, Sanofi, B. Braun Melsungen AG, Acon Laboratories, Inc., Becton, Dickinson And Company, Ypsomed, Terumo Corporation, and other prominent players. The companies are consistently focusing on offering a wide range of sophisticated diabetes care devices to maintain and expand their presence in several regions of the world.
Recent Developments
- In May 2021, Bigfoot Biomedical, a US-based medical technology startup, announced to have received FDA clearance for the Bigfoot Unity Diabetes Management System. This smartpen cap for insulin pens has been devised to treat Type1 and Type2 diabetes.
- In April 2021, BIOCORP, a French medical device company announced the launch of ‘Mallya’, a medical device in collaboration with Roche Diabetes Care France. ‘Mallya’ is a smart insulin pen device that can accurately collect and transfer insulin data.
Scope of the Report
| Attributes | Details |
| Years Considered | Historical data – 2017-2020 |
| Base Year – 2020 | |
| Forecast – 2021 – 2027 | |
| Facts Covered | Revenue in USD Million |
| Market Coverage | North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa |
| Product Service/Segmentation | By Type, By End-User, By Region |
| Key Players | Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Rossmax International Ltd., Medtronic PLC, Sinocare, Inc., Ascensia Diabetes Care Holdings AG, Abbott, Rossmax International Ltd., Arkray, Inc., Dexcom, Inc., Bionime Corporation, Lifescan, Dr. Morepen, Sanofi, B. Braun Melsungen AG, Acon Laboratories, Inc., Becton, Dickinson And Company, Ypsomed, Terumo Corporation, and other prominent players |
By Type
- Blood Glucose Monitoring Systems
- Self-Monitoring Blood Glucose Monitoring Systems
- Test Strips/Test Papers
- Lancets/Lancing Devices
- Insulin Delivery Devices
- Insulin Pumps
- Insulin Pens
- Insulin Syringes and Needles
- Diabetes Management Mobile Applications
By End-User
- Hospitals
- Diabetes Specialty Clinics
- Self-Home Healthcare
By Region
- North America
- Europe
- Asia-Pacific (APAC)
- Latin America (LATAM)
- Middle-East & Africa (MEA)
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary and Secondary Sources
2.2. Quantitative Research
2.2.1. Primary and Secondary Sources
2.3. Breakdown of Primary Research Respondents
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Industry Participants
2.5. Key Questionnaire asked during Primary Interviews
2.6. Key Primary Responses
2.7. Market Size Estimation
2.8. Assumption for the Study
2.9. Market Breakdown & Data Triangulation
3. Executive Summary
4. Global Diabetes Care Devices Market Market – Industry Insights
4.1. DROC Analysis
4.1.1. Growth Drivers
4.1.2. Restraints
4.1.3. Opportunity
4.1.4. Challenges
4.2. Recent Developments / Technical Landscape
4.3. Regulatory Framework
4.4. Porter’s Five Forces Analysis
4.5. Value Chain Analysis
4.6. Strategic Outlook
5. Global Diabetes Care Devices Market Overview
5.1. Market Estimates & Forecast by Value, 2017-2027
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1.1. Blood Glucose Monitoring Systems
5.2.1.1.1. Self-Monitoring Blood Glucose Monitoring Systems
5.2.1.1.2. Test Strips/Test Papers
5.2.1.1.3. Lancets/Lancing Devices
5.2.1.2. Insulin Delivery Devices
5.2.1.2.1. Insulin Pumps
5.2.1.2.2. Insulin Pens
5.2.1.2.3. Insulin Syringes And Needles
5.2.1.3. Diabetes Management Mobile Applications
5.2.2. By End-User
5.2.2.1. Hospitals
5.2.2.2. Diabetes Specialty Clinics
5.2.2.3. Self-Home Healthcare
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. Asia-Pacific (APAC)
5.2.3.4. Latin America (LATAM)
5.2.3.5. Middle-East & Africa (MEA)
6. North America Diabetes Care Devices Market Overview
6.1. Market Size and Forecast
6.1.1. By Value (USD Million), 2017-2027
6.2. Market Share and Forecast
6.2.1. By Application
6.2.2. By Regime
6.2.3. By Country
6.2.3.1. U.S.
6.2.3.2. Canada
7. Europe Diabetes Care Devices Market Overview
7.1. Market Size and Forecast
7.1.1. By Value (USD Million), 2017-2027
7.2. Market Share and Forecast
7.2.1. By Application
7.2.2. By Regime
7.2.3. By Country
7.2.3.1. Germany
7.2.3.2. U.K.
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. Russia
7.2.3.7. Netherlands
7.2.3.8. Rest of Europe
8. APAC Diabetes Care Devices Market Overview
8.1. Market Size and Forecast
8.1.1. By Value (USD Million), 2017-2027
8.2. Market Share and Forecast
8.2.1. By Application
8.2.2. By Regime
8.2.3. By Country
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. South Korea
8.2.3.5. Rest of APAC
9. LATAM Diabetes Care Devices Market Overview
9.1. Market Size and Forecast
9.1.1. By Value (USD Million), 2017-2027
9.2. Market Share and Forecast
9.2.1. By Application
9.2.2. By Regime
9.2.3. By Country
9.2.3.1. Mexico
9.2.3.2. Brazil
9.2.3.3. Rest of LATAM
10.MEA Diabetes Care Devices Market Overview
10.1. Market Size and Forecast
10.1.1. By Value (USD Million), 2017-2027
10.2. Market Share and Forecast
10.2.1. By Application
10.2.2. By Regime
10.2.3. By Country
10.2.3.1. Saudi Arabia
10.2.3.2. UAE
10.2.3.3. South Africa
10.2.3.4. Turkey
10.2.3.5. Rest of Europe
11.Competitive Landscape
11.1.1. List of Key Players and Their Offerings
11.1.2. Market Share / Ranking Analysis (2020)
11.1.3. Competitive Benchmarking, By Operating Parameters
12.COVID-19 Impact
12.1. Future Impact
12.2. Key Developments during COVID-19
12.3. Impact on Market
12.3.1. Different Scenario
12.3.2. Impact on Companies
12.4. Regional Impact
13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
13.1. Novo Nordisk A/S
13.2. F. Hoffman-La Roche Ltd.
13.3. Rossmax International Ltd.
13.4. Medtronic Plc
13.5. Sinocare, Inc.
13.6. Ascensia Diabetes Care Holdings AG
13.7. Abbott
13.8. Rossmax International Ltd.
13.9. Arkray, Inc.
13.10. Dexcom, Inc.
13.11. Bionime Corporation
13.12. Lifescan
13.13. Dr. Morepen
13.14. Sanofi
13.15. B. Braun Melsungen AG
13.16. Acon Laboratories, Inc.
13.17. Becton, Dickinson And Company
13.18. Ypsomed
13.19. Terumo Corporation
13.20. Other Prominent Players
14. Key Strategic Recommendations
* Financial information of non-listed Companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.
List of Figures
Fig: Global Diabetes Care Devices Segmentation
Fig: Global Diabetes Care Devices Value Chain Analysis,
Fig: Company Market Share Analysis, 2020
Fig: Global Diabetes Care Devices Size, By Value (USD Million), 2017-2027
Fig: Global Diabetes Care Devices Share (%), By Application, By Value, 2017-2027
Fig: Global Diabetes Care Devices Share (%), By End User, By Value, 2017-2027
Fig: Global Diabetes Care Devices Share (%), By Country, By Value, 2017-2027
Fig: North America Diabetes Care Devices Size, By Value (USD Million), 2017-2027
Fig: North America Diabetes Care Devices Share (%), By Application, By Value, 2017-2027
Fig: North America Diabetes Care Devices Share (%), By End User, By Value, 2017-2027
Fig: North America Diabetes Care Devices Share (%), By Country, By Value, 2017-2027
Fig: Europe Diabetes Care Devices Size, By Value (USD Million), 2017-2027
Fig: Europe Diabetes Care Devices Share (%), By Application, By Value, 2017-2027
Fig: Europe Diabetes Care Devices Share (%), By End User, By Value, 2017-2027
Fig: Europe Diabetes Care Devices Share (%), By Country, By Value, 2017-2027
Fig: the Asia-Pacific Diabetes Care Devices Size, By Value (USD Million), 2017-2027
Fig: the Asia-Pacific Diabetes Care Devices Share (%), By Application, By Value, 2017-2027
Fig: the Asia-Pacific Diabetes Care Devices Share (%), By End User, By Value, 2017-2027
Fig: Asia-Pacific Diabetes Care Devices Share (%), By Country, By Value, 2017-2027
Fig: Latin America Diabetes Care Devices Size, By Value (USD Million), 2017-2027
Fig: Latin America Diabetes Care Devices Share (%), By Application, By Value, 2017-2027
Fig: Latin America Diabetes Care Devices Share (%), By End User, By Value, 2017-2027
Fig: Latin America Diabetes Care Devices Share (%), By Country, By Value, 2017-2027
Fig: Middle East & Africa Diabetes Care Devices Size, By Value (USD Million), 2017-2027
Fig: Middle East & Africa Diabetes Care Devices Share (%), By Application, By Value, 2017-2027
Fig: Middle East & Africa Diabetes Care Devices Share (%), By End User, By Value, 2017-2027
Fig: Middle East & Africa Diabetes Care Devices Share (%), By Region, By Value, 2017-2027
List of Tables
Table: Global Diabetes Care Devices Size, By Application, By Value, 2017-2027
Table: Global Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027
Table: Global Diabetes Care Devices Size, By Region, By Value (USD Million), 2017-2027
Table: North America Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027
Table: North America Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027
Table: North America Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027
Table: Europe Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027
Table: Europe Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027
Table: Europe Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027
Table: Latin America Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027
Table: Latin America Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027
Table: Latin America Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027
Table: Novo Nordisk A/S Financial Analysis
Table: Novo Nordisk A/S Business Overview
Table: F. Hoffman-La Roche Ltd. Financial Analysis
Table: F. Hoffman-La Roche Ltd. Business Overview
Table: Rossmax International Ltd. Financial Analysis
Table: Rossmax International Ltd. Business Overview
Table: Medtronic PLC Financial Analysis
Table: Medtronic PLC Business Overview
Table: Sinocare, Inc. Financial Analysis
Table: Sinocare, Inc. Business Overview
Table: Ascensia Diabetes Care Holdings AG Financial Analysis
Table: Ascensia Diabetes Care Holdings AG Business Overview
Table: Abbott Financial Analysis
Table: Abbott Business Overview
Table: Rossmax International Ltd. Financial Analysis
Table: Rossmax International Ltd. Business Overview
Table: Arkray, Inc. Financial Analysis
Table: Arkray, Inc. Business Overview
Table: Dexcom, Inc. Financial Analysis
Table: Dexcom, Inc. Business Overview
Table: Bionime Corporation Financial Analysis
Table: Bionime Corporation Financial Analysis
Table: Lifescan Financial Analysis
Table: Lifescan Business Overview
Table: Dr. Morepen Financial Analysis
Table: Dr. Morepen Business Overview
Table: Sanofi Financial Analysis
Table: Sanofi Business Overview
Table: B. Braun Melsungen AG Financial Analysis
Table: B. Braun Melsungen AG Business Overview
Table: Acon Laboratories, Inc. Financial Analysis
Table: Acon Laboratories, Inc. Business Overview
Table: Becton, Dickinson And Company Financial Analysis
Table: Becton, Dickinson And Company Business Overview
Table: Ypsomed Financial Analysis
Table: Ypsomed Business Overview
Table: Terumo Corporation Financial Analysis
Table: Terumo Corporation Business Overview
Market Segmentation
By Type
- Blood Glucose Monitoring Systems
- Self-Monitoring Blood Glucose Monitoring Systems
- Test Strips/Test Papers
- Lancets/Lancing Devices
- Insulin Delivery Devices
- Insulin Pumps
- Insulin Pens
- Insulin Syringes and Needles
- Diabetes Management Mobile Applications
By End-User
- Hospitals
- Diabetes Specialty Clinics
- Self-Home Healthcare
By Region
- North America
- Europe
- Asia-Pacific (APAC)
- Latin America (LATAM)
- Middle-East & Africa (MEA)
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.